Moreover, SNHG12 overexpression or miR-181a inhibition significantly increased the the MDR of NSCLC cells, while the mutant SNHG12 overexpression had no obvious effect on the MDR (Figure 3D-3F). This evidence concerns the gene SNHG12 and non-small cell lung carcinoma.